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Abstract Probiotics, gut-colonizing microorganisms capa-
ble of conferring a number of health benefits to their hosts,
are highly desirable as animal feed supplements. Members
of the Gram-positive genus Bacillus are often utilized as
probiotics, since endospores formed by those bacteria render
them highly resistant to environmental extremes and there-
fore capable of surviving gastrointestinal tract conditions. In
this study, 84 distinct bacterial colonies were obtained from
bovine chyme and 29 isolates were determined as Bacillus
species. These isolates were principally screened for their
antimicrobial activity against a group of two Gram-positive
and four Gram-negative bacteria, including known human and
animal pathogens such as Salmonella enterica, Klebsiella
pneumoniae, Pseudomonas aeruginosa, and Staphylococcus
aureus. Seven strains displaying strong antimicrobial activity
against the test cohort were further evaluated for other prop-
erties desirable from animal probiotics, including high
spore-forming capacity and adhesiveness, resistance to
pH extremes and ability to form biofilms. The isolates
were found to resist simulated gastrointestinal conditions
and most of the antibiotics tested. In addition, plasmid pres-
ence was checked and cytotoxicity tests were performed to
evaluate the potential risks of antibiotic resistance transfer and
unintended pathogenic effects on host, respectively. We pro-
pose that the bacterial isolates are suitable for use as animal
probiotics.
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Introduction
The widespread and intensive use of antibiotics for thera-
peutic purposes has led to a considerable increase in the
number of antibiotic-resistant pathogenic strains, resulting
in frequent occurrence of serious and hard-to-treat infections
in both humans and livestock (Barbosa and Levy 2000;
Barbosa et al. 2005; Chaiyawan et al. 2010). As such, there
has been an increasing concern about non-therapeutic uses
of antibiotics, ultimately culminating in bans of their use as
animal feed additives. The European Parliament and the
Council of the European Union have encouraged the devel-
opment of alternative products to replace antibiotics as feed
supplements for growth promotion (Santini et al. 2010; The
European Parliament and the Council of the European
Union 2003). Consequently, there is an ongoing search for
replacement products capable of enhancing growth and
preventing disease (Chaiyawan et al. 2010; Santini et al.
2010). An effective and safe alternative to antibiotic imple-
mentation is the use of probiotics, which protect the animal
from pathogens by improving the microbial balance in the
gastrointestinal tract to exclude potentially harmful bacteria
(Chaiyawan et al. 2010; Modesto et al. 2009; Patterson and
Burkholder 2003; Santini et al. 2010).
Probiotics are beneficial live microorganisms primarily
including various species of bacteria and fungi (Duc et al.
2004; Lutful Kabir 2009). Probiotics influence the host organ-
isms’ health by maintaining the normal intestinal microbiota,
preventing the growth of pathogenic microorganisms, promot-
ing digestion and intake of feed, and inducing the immune
system (Kim et al. 2009; Lutful Kabir 2009). As such, the use
of probiotics on livestock enhances the growth of animals,
improves efficiency of feed conversion, and decreases the rate
of mortality (Kim et al. 2009; Lutful Kabir 2009). Probiotic
microorganisms should ideally be non-pathogenic and non-
toxic, improve growth of the host animal, and be stable and
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active during processing and storage. In addition, probiotics
should be able to survive and continue their metabolic activ-
ities in gastrointestinal conditions and produce compounds
that inhibit the growth of pathogenic microorganisms (Kim
et al. 2009; Patterson and Burkholder 2003).
A number of bacterial species are currently used as pro-
biotics, mostly in genera Bacillus, Bifidobacterium,
Enterococcus, Escherichia, Lactobacillus, Lactococcus, and
Streptococcus (Patterson and Burkholder 2003). Some yeast
species, such as Saccharomyces cerevisiae, are also utilized as
probiotics (Lutful Kabir 2009).
The most common probiotics used in humans are species
of Lactobacillus and Bifidobacterium, while Bacillus,
Enterococcus, and Saccharomyces species are frequently
used in livestock (Patterson and Burkholder 2003).
Bacillus species in particular are advantageous for use as
probiotics, since members of this genus are spore-formers
displaying high resistance to heat, chemicals, and other
stress factors (Cartman et al. 2008; Chaiyawan et al. 2010;
Nicholson et al. 2000; Setlow 2006., Bacillus spores can
survive in harsh pH conditions of the gastric fluids (Cutting
2011) and reach the small intestine relatively unharmed,
making them suitable for use as feed supplements. In addi-
tion, spores can be kept for a long time in desiccated form
with little to no loss of viability, allowing for ease of trans-
port (Duc et al. 2004; Mazza 1994). Bacillus subtilis, B.
clausii, B. cereus, B. coagulans, and B. licheniformis are the
Bacillus species most widely researched and used as animal
probiotics (Cutting 2011).
In this study, novel bacterial strains were isolated from
bovine chyme samples, and Bacillus strains obtained in this
manner were characterized and screened for their potential
to be used as animal probiotics. Criteria utilized for assess-
ing probiotic capacity include survival in gastrointestinal
tract (GIT) conditions, lack of toxicity and invasiveness,
ability to adhere to the small intestine, and inhibition of
pathogenic bacteria in the GIT by competitive exclusion or
synthesis of antimicrobial compounds.
Materials and methods
Bacillus isolation and growth conditions
Microorganisms were isolated from chyme samples of eight
male cattle between 2 and 4 years of age. The small intestine
was removed as a whole and chyme samples were collected
by squeezing the intestinal contents into sterile tubes.
Isolation of the microorganisms was performed as described
by Lalloo et al. (2007) with minor modifications. An
amount of 1 g of chyme fluid from each sample was sus-
pended in 3 ml of 0.9 % NaCl solution and inoculated in
9 ml of nutrient broth (NB). Samples were incubated at
37 °C for 24 h, followed by incubation at 45 °C for
10 min to initiate spore formation. Then, 50 % (v/v) ethanol
was added to a volume of 20 ml and the suspension was
incubated at 20 °C for 1 h. Centrifugation was performed at
12,000 g for 30 s, the supernatant was decanted, and pellets
were incubated at 105 °C for 5 min. Dry pellets were
resuspended in 20 ml of 0.9 % NaCl solution and serially
diluted in ten-fold increments.
An amount of 150 μl of each dilution was spread on
MYP (Mannitol–Egg Yolk–Polymyxin) agar plates and
incubated at 37 °C for 24 h. Bacillus species were
differentiated according to their ability to ferment man-
nitol or degrade lecithin, while polymyxin was utilized to
inhibit the growth of Gram-negative bacteria. Single col-
onies with distinct morphologies were collected and
transferred on Luria–Bertani (LB) agar plates. Cultures
were incubated at 37 °C and 125 rpm until visible
colony formation, and stored at 4 °C to maintain viabil-
ity. Cultures were maintained at −80 °C in 30 % glycerol
for long-term storage.
Antimicrobial activity
Antimicrobial activity assay was adapted from the method
described by Saravanakumari and Mani (2010). Overnight
incubated cultures of the isolates were horizontally streaked
on LB agar plates and incubated at 37 °C for 48 h. After the
incubation period, plates were exposed to chloroform vapor
for 90 min for the inactivation of active cells. Plates were
aerated for 20 min to completely remove residual chloro-
form by vaporization and plate covers were subsequently
changed (Barbosa et al. 2005). Representative bacteria
(Table 1) were then streaked vertically on the horizontally
streaked colonies and plates were incubated at 37 °C for
24 h. Inhibition on the bacterial growth line (Table 1) was
assessed to evaluate the antimicrobial activity of isolates
against each representative strain.
Table 1 Microorganisms used in the present study; all strains were
obtained from RSHM (Refik Saydam National Type Culture Collec-
tion Laboratory, Ankara, Turkey)
Bacterial species Strains
Bacillus subtilis ATCC 6633 (RSHM 03013)
Bacillus cereus RSHM 709
Staphylococcus aureus ATCC 25923
(RSHM 96090/07035)
Escherichia coli DH5α, RSHM 888
Pseudomonas aeruginosa ATCC 29212 (RSHM 03015)
Klebsiella pneumoniae ATCC 10031 (RSHM 06017)
Salmonella enterica ATCC 13311 (RSHM 4059,
CIP 5858, NCTC 74)
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Sporulation efficiency
Sporulation efficiencies of the isolates were measured as
described by Barbosa et al. (2005). Isolates were inoculated
(0.1 %v/v) in Difco Sporulation Medium (DSM) and incu-
bated at 125 rpm and 37 °C for 24 h. After 24 h, serial
dilutions were prepared in ten-fold increments and spread on
LB agar plates before and after heat exposure at 80 °C for
20 min. Plates were incubated at 37 °C overnight and
colony-forming unit (CFU) numbers were counted; colony
growth before and after heat exposure was compared to
assess the sporulation capacities of the isolates.
Spore formation
Spores were harvested and purified to test the spore tolerance
of each isolate to simulated gastric fluids and bile salts.
Cultures were grown in 50 ml DSM medium at 37 °C,
250 rpm for 24 h and centrifuged at 1,500 g for 5 min to
refresh the medium of spores. Harvested spores were then
inoculated in DSM medium and incubated at 37 °C and
250 rpm for 48 h. After the incubation period, spores were
centrifuged at 5,000 g for 30 min; spore pellets were washed
with 20 ml sterile distilled water and resuspended in 5 ml
sterile water. Spores of each isolate were stored at 4 °C for
further use.
Resistance to simulated gastric fluids
Vegetative cells of the isolates were tested for survival capac-
ity in simulated gastric fluids as described by Barbosa et al.
(2005), Hong et al. (2008), and Patel et al. (2009) with minor
modifications. Briefly, bacteria grown overnight were inocu-
lated in LB broth (pH=2.0, adjusted with 37 % HCl) and
incubated at 37 °C and 125 rpm for 30 min. Samples were
then serially diluted, spread on LB agar plates and incubated at
37 °C for 24 h. Colonies were counted and compared with
those of control cultures grown in unmodified LB broth.
Spore tolerance to simulated gastric fluids was also tested
as described by Barbosa et al. (2005), Duc et al. (2004),
Hong et al. (2008), and Patel et al. (2009). Approximately
108–109 purified spores per ml were resuspended in 0.85 %
NaCl solution (pH=2, adjusted with 37 % HCl), incubated
and spread on LB agar plates as described for vegetative
cells. Spores resuspended in 0.85 % NaCl solution with no
pH modification served as controls. Colonies were counted
and compared with those of controls to assess the tolerance
of spores to simulated gastric fluid conditions.
Bile salt tolerance
Bile salt tolerances of vegetative cells were tested as described
by Barbosa et al. (2005). Overnight cultures of isolated
bacteria were inoculated in fresh LB supplemented with
0.2 % bile salts (50 % cholic acid sodium salt, 50 % deoxy-
cholic acid sodium salt; Sigma-Aldrich, USA) and incubated
at 37 °C and 125 rpm. Bacteria inoculated in fresh LB not
containing bile salts were incubated in parallel as controls.
Aliquots were taken after 3 h of incubation, serially diluted
and plated on LB agar; colonies were counted after incubation
at 37 °C for 24 h.
Bile salt tolerances of spores were also assayed as de-
scribed by Barbosa et al. (2005). Spores were purified as
described by Henriques et al. (1995) and approximately
108–109 purified spores per ml were resuspended in an iso-
tonic buffer [Bott and Wilson salts: 1.24 % K2HPO4, 0.76 %
H2PO4, 0.1 % trisodium citrate, 0.6 % (NH4)2SO4, pH=6.7)]
containing 0.2 % bile salts. Spores were incubated at 37 °C
and 125 rpm, aliquots were taken at 0, 1, and 3 h and colony
counts were performed to compare survival efficiencies.
Spores resuspended in isotonic buffer not containing bile salts
were incubated in parallel as controls.
Biofilm formation
Biofilm formation abilities of isolates were tested as de-
scribed by Barbosa et al. (2005) with minor modifications.
Instead of Sterlini–Mandelstam medium, a biofilm growth
medium consisting of LB medium (pH=7) supplemented
with 0.15 mol/l ammonium sulfate, 0.1 mol/l potassium
phosphate, 0.034 mol/l sodium citrate, 0.001 mol/l MgSO4
and 0.1 % glucose, (Hamon and Lazazzera 2001) was uti-
lized in this study. Isolates were grown in this biofilm
growth medium to exponential phase, transferred to 3 ml
of the same medium in a culture tube and incubated at 37 °C
without agitation to an optical density of ∼0.01 at 600 nm.
An uninoculated culture tube and a culture tube freshly
inoculated with exponential phase cells were utilized as
controls. Tubes were rinsed with water and stained with a
1 % crystal violet solution for 15 min. Excess stain was then
removed by washing. A ring of staining on the medium
suggests that the bacteria are capable of forming biofilm.
Antibiotic susceptibility
Antibiotic resistances of the isolates were tested as described
by Chaiyawan et al. (2010) and Santini et al. (2010) with
modifications. Ampicillin, kanamycin, chloramphenicol,
erythromycin, vancomycin, neomycin, ciprofloxacin,
streptomycin, and gentamicin were the antibiotics tested.
Two-fold serial dilutions of antibiotics were prepared in con-
centrations ranging between 1 and 256 μg/ml. Next, 160 μl of
fresh LB broth, 20 μl of appropriate dilutions of antibiotics,
and 20 μl of overnight grown isolates diluted to 106CFU/ml
were added in each well of 96-well microtiter plates.
Uninoculated LB broth and isolates inoculated in antibiotic-
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free LB broth were utilized as negative and positive controls,
respectively. Plates were incubated at 37 °C for 24 h and the
minimum inhibitory concentrations of each antibiotic were
determined by comparing sample turbidity at 620 nm to
control wells.
Plasmid DNA extraction and purification
DNA minipreparation was performed to observe plasmid
presence in isolates. Isolates were grown overnight at 37 °
C and 250 rpm in LB broth, confluent bacterial cultures
were centrifuged at 12,000 g for 3 min to obtain cell pellets
and plasmid DNA was extracted from the pellet of each
isolate using QIAprep Spin Miniprep Kit (Qiagen,
Germany). Gel electrophoresis was performed to determine
whether the isolates carry plasmid DNA.
Adhesion and invasion
Adhesion and invasion assays of Bacillus isolates were per-
formed as described by Rowan et al. (2000, 2001) with minor
modifications. HT-29 cell monolayers were grown in DMEM
supplemented with 10 % FBS and 1 % penicillin-
streptomycin at 37 °C in 5 % CO2 environment. Cells were
seeded in 24-well plates containing approximately 3×105
cells per well and incubated overnight at 37 °C in 5 % CO2.
Before adhesion and invasion assays, HT-29 cell monolayers
were washed three times with DMEM and inoculated with
1 ml of bacterial cultures previously washed with DMEM
containing 10 % FBS. 24-well plates were incubated at 37 °
C in 5 % CO2 for 2 h. After the incubation period, HT-29 cells
were washed with DMEM to remove nonadherent bacteria.
For the adhesion assay, HT-29 cells with adherent bacteria in
1 ml of DMEM supplemented with 10 % FBS were incubated
for another 2 h at 37 °C in 5 % CO2. For the invasion assay,
infected cells were incubated for 2 h in 1 ml of DMEM
containing 10 % FBS and 100 μg of gentamicin per ml at
37 °C in 5 % CO2. Cells in both assay groups were then
washed three times with DMEM and lysed with 1 ml of 1 %
(v/v) Triton X-100 for 5 min at 37 °C. Samples from lysed
cells were serially diluted and spread on BHI agar plates for
colony counting. Bacillus subtilisRSKK 03013 (ATCC 6633)
and B. cereus RSKK709 were utilized as controls.
Cell cytotoxicity
Cytotoxic effects of isolates were tested as described by
Rowan et al. (2000, 2001) and Hong et al. (2008) with
modifications. An 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT) based in vitro toxicology assay
kit (Sigma) was used to measure total cellular metabolic
activity, the presence of which directly corresponds to the lack
of cytotoxic effects. HT-29 cell monolayers were grown in
DMEM supplemented with 10 % FBS and 1 % penicillin-
streptomycin at 37 °C in 5 % CO2 environment. The cells
were then transferred to 96-well plates with approximately 5×
104 cells in each well and incubated overnight at 37 °C in 5 %
CO2 atmosphere. Filter sterilized (by 0.2-μm pore size mem-
branes) supernatants of overnight grown bacteria (BHI, 37 °C,
and 125 rpm) were added to test plates before and after heat
treatment (95 °C, 10 min). Four replicates were done for the
supernatant of each isolate, and 1%Triton X-100 (Sigma) and
PBS were used as positive and negative controls, respectively.
Cells inoculated with bacterial supernatant were incubated
overnight at 37 °C in 5 % CO2. After the incubation period,
the medium in each well was removed and 100 μl of DMEM
supplemented with PBS containing 0.5 % MTTwas added to
wells. Plates were incubated at 37 °C for 4 h, after which
100 μl of MTT solubilization solution (Sigma) was added to
each well. The absorbance of the wells was measured at
570 nm by using a microplate reader (SpectraMax M5;
Spectra Lab.). Background absorbance of well plates was also
measured (at 690 nm) and subtracted from 570 nm measure-
ments. Toxicities of the supernatants to HT-29 cells were
determined by using the equation (1-optical density of the test
sample/optical density of the negative control) × 100, where
the resulting percentage represents the ratio of cellular respi-
ration in the sample to respiration in an equal number of
healthy cells (Rowan et al. 2001). Bacillus subtilis RSKK
03013 (ATCC 6633) and B. cereus RSKK709 were utilized
as controls.
Results
Bacillus isolation and growth conditions
Chyme samples were collected from eight different male
beef cattle for potential Bacillus probiotic isolation and 84
distinct isolates were obtained in total. Isolates were grown
on MYP agar and 29 were found to be members of the genus
Bacillus. All 29 isolates were observed to sporulate follow-
ing heat exposure and inoculation in DSM broth. Light and
scanning electron microscopy images were taken to confirm
isolate morphology; all isolates were found to be bacilli
(data not shown).
Antimicrobial activity
Antimicrobial effects of the selected Bacillus isolates were
tested against different indicator strains, including four
Gram-negative and two Gram-positive bacteria (Table 1).
While all isolates displayed some antimicrobial activity,
seven (STF4, STF8, STF9, STF10, STF15, STF25, and
STF26) showed particularly strong inhibitory activity
against the tested bacteria (Table 2). These seven isolates
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were therefore chosen for further study, identified by 16S
rRNA sequencing (Table 3) and imaged by SEM to observe
their cell morphologies. STF4, STF8, STF15, and STF26
were all effective in preventing the growth of S. aureus,
while only STF4 showed inhibitory effect on P. aeruginosa.
Further, while STF8, STF9, STF10, and STF25 all dis-
played a clear inhibition zone on the growth line of B.
subtilis, only STF26 could effectively inhibit the growth of
S. enterica. STF26 and STF4 also showed stronger antimi-
crobial activity on E. coli and K. pneumoniae compared to
other isolates.
Sporulation efficiency
Sporulation efficiencies of the isolates STF4, STF8, STF9,
STF10, STF15, STF25, and STF26 were tested by inducing
spore formation in a sporulation medium and evaluating the
number of colonies formed before and after heat exposure at
80 °C. Colony numbers were compared and survival per-
centages were subsequently calculated from this data. The
results are listed as percentages in Table 3. All isolates were
spore-formers, although their sporulation efficiencies varied
greatly. It is notable that while STF25 and STF26 had
relatively low sporulation efficiencies, those isolates prolif-
erated very rapidly in sporulation medium and could there-
fore have been resistant to the associated stresses.
Sporulation rates for those isolates increased substantially
after longer incubation times (48 and 60 h), suggesting that
STF25 and STF26 were disinclined to sporulate in the
medium utilized for a certain time period. While other iso-
lates also yielded higher sporulation rates after longer peri-
ods of incubation, those increases were not as drastic as the
1.5- and 1.6-fold increases seen in STF25 and STF26.
Resistance to simulated gastric fluids
Vegetative cells of the isolates STF4, STF8, STF9, STF10,
STF15, STF25, and STF26 were tested for survival in
simulated gastric fluids. All tested isolates were resistant to
simulated gastric fluid conditions, although their survival
Table 2 Inhibitory activity of
isolates as inferred by diameters
of inhibition zones
Signs correspond to degrees of
inhibitory effect on growth from
− (no inhibition) to +++; ±
reflects reduction in growth but
not complete inhibition
Isolate Indicator strains
S. aureus P. aeruginosa E. coli B. subtilis K. pneumoniae S. enterica
STF1 − − − + − −
STF2 − − − − − −
STF3 − − − − − −
STF4 ++ ++ ++ − ++ −
STF5 + ± − ± ± −
STF6 ± ± − + ± ±
STF8 ++ ± + +++ − ±
STF9 + − − ++ − −
STF10 +± ± ± ++ − −
STF11 − − − − ± −
STF12 ± + − ± − ±
STF13 + − − ± +± ±
STF14 + − − − + ±
STF15 +++ ± ± ± − −
STF16 ± − − ± − ±
STF18 ± − − − − ±
STF19 ± − − ± ± ±
STF20 − − + ± ± ±
STF21 ± + − − − −
STF22 ± +± − − ± ±
STF23 − + − + +± −
STF24 − + + − − −
STF25 ± ± + +++ − −
STF26 +++ ± +++ +± ++± ++
STF27 + − − + − −
STF28 − ± − ± + −
STF29 ± ± − ± − ±
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rates were different (Table 3). Tolerance of purified spores
of STF4, STF8, STF9, STF10, STF15, STF25, and STF26
to low pH condition of gastric fluids was also tested after
30 min and 1 h of incubation. After 30 min, there was no
reduction in the number of spores compared to controls.
After 1 h incubation, there were 2-log reductions in the
viability of STF15 and STF25 spores and no difference in
STF4, STF8, STF9, STF10, and STF26 spores compared to
controls.
Bile salt tolerance
Isolates were analyzed for their resistance to intestinal con-
ditions by testing survival of both vegetative cells and spores
in bile salts medium. Vegetative cells of all isolates were
capable of surviving exposure to bile salts (Table 3). At 0
and 1 h, no reduction was observed in the number of germi-
nating spores of any isolate exposed to bile salts. After 3 h
incubation in LB supplemented with bile salts, a 2-log reduc-
tion was observed in STF25; 1-log reductions were present in
STF4, STF8, STF9, and STF10, a slight reduction was ob-
served in STF26, and no reduction was found in STF15.
Biofilm formation
When grown in LB broth, isolates STF9, STF10, STF15,
and STF26 formed highly viscous structures on the bottom
of the tubes. After the biofilm assay, these isolates formed a
notable ring of crystal violet, suggesting that the isolates are
capable of forming biofilms (Table 3).
Antibiotic susceptibility and plasmid presence
Antibiotic selection and determination of resistance or sen-
sitivity of isolates against chosen antibiotics were performed
according to the microbiological breakpoints used by SCAN
(Scientific Committee on Animal Nutrition) (von Wright
2005). Minimum inhibitory concentration (MIC) values
are displayed in Table 4. Of the isolates tested, all except
STF4 were resistant to ampicillin, vancomycin and genta-
micin; four isolates (STF8, STF9, STF15, and STF25) were
resistant to kanamycin while another four (STF9, STF15,
STF25, and STF26) were resistant to chloramphenicol.
STF4 and STF8 were sensitive to erythromycin, whereas
other isolates displayed resistance to this antibiotic. MIC
values of STF4 and STF26 against neomycin were lower
than the breakpoints mentioned in the SCAN report; there-
fore, they were considered as sensitive to neomycin. Three
cultures (STF15, STF25, and STF26) showed resistance to
ciprofloxacin and only STF26 exhibited low MIC values to
streptomycin.
Since the isolates were resistant to many of the antibiotics
tested, it is possible for one or more isolates to carry plas-
mids bearing antibiotic resistance genes, which may be then
acquired by pathogenic organisms. As this outcome is high-
ly undesirable, plasmid extraction and gel electrophoresis
were performed to determine whether the observed resistan-
ces were transmissible. No plasmid presence was detected in
the isolates STF4, STF8, STF9, STF10, STF15, and STF26;
only STF25 displayed a faint band after gel electrophoresis
(Fig. 1).
Adhesion and invasion
Abilities of Bacillus isolates to adhere to HT-29 cells were
tested. We observed that all isolates tested could adhere to
HT-29 cells (Table 5). STF9 could not grow in BHI broth;
therefore, we could not perform the test for this isolate.
STF4 showed the strongest adhesion with a percentage of
2.5 % while STF15 showed the lowest with 0.002 %.
Invasion properties of Bacillus isolates were also assayed
as mentioned above. Assay results demonstrate that none of










(Closest known species) (Vegetative form) (Vegetative form)
STF4 Paenibacillus xylanexedens 79.9 + + −
STF8 Bacillus subtilis 127.02 +++ ++++ −
STF9 Bacillus subtilis 22.75 +++ +++ +
STF10 Bacillus licheniformis 173.91 +++ ++ +
STF15 Bacillus pumilus 15.28 + +++++ +
STF25 Bacillus licheniformis 35.2 + ++++ −
STF26 Bacillus pumilus 36.7 ++ ++++ +
Sporulation efficiency is given as the percentage of survivors
Plus signs under survival columns reflect the degrees of survival in simulated gastric fluid, + denoting the lowest survival and +++++ the highest.
Plus signs under the biofilm formation column reflect presence of biofilm formation while minus signs denote absence of biofilm formation
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the bacteria were capable of invading HT-29 cells, with the
possible exception of STF9, which failed to grow in the
assay medium (Table 5). Bacillus subtilis ATCC 6633 and
B. cereus RSHM709 displayed higher adhesion rates com-
pared to our isolates (except STF4), though both reference
strains could also invade cells. While B. subtilis ATCC 6633
had minor invasion capacity (0.050 %), the B. cereus strain
was highly invasive (0.338 %).
Cell cytotoxicity
The cell cytotoxicities of the supernatants of 18 h grown
isolates in BHI were tested by MTT assay. STF9 could not
grow in BHI broth and was therefore not a subject for this
test. STF8 and STF15 both had heat-stable toxic materials;
though their cytotoxicities were different. In addition, STF4,
STF25, and STF26 contained low amounts of heat-stable
toxic materials in their cell-free supernatants. It is curious
that unmodified STF10 supernatant showed no toxicity to the
HT-29 cell line, but the presence of a toxic material was
observed after heating (Table 5). Bacillus subtilis ATCC 6633
supernatant displayed minor cytotoxicity both prior to and after
heating, while B. cereus RSHM709 expressed both heat-labile
and heat-stable toxins.
Discussion
Bacillus species are commonly used as probiotics, as these
spore-forming bacteria can tolerate the harsh environmental
conditions associated with the gastrointestinal tract. Bacillus
species have been incorporated in commercial probiotic prod-
ucts, either alone or alongside consortia of other bacteria
(Cutting 2011). Bactisubtil (B. cereus strain IP5832),
Enterogermina (B. clausii), Biosubtyl Nha Trang (B. pumilus),
and Bispan (B. polyfermenticus) are examples of commercial-
ly available Bacillus probiotics (Duc et al. 2004; Cutting
2011). Further, the production of natto, a fermented soybean
product originating in Japan, involves the use of B. subtilis to
facilitate the fermentation process, indicating that Bacillus
species have been safely used in foodstuffs for a considerable
period of time (Hong et al. 2008).
Bacillus species potentially suitable for use as probiotics
were previously reported from the chicken and fish gastroin-
testinal tracts (Barbosa et al. 2005; Vijayabaskar and
Somasundaram 2008). In a similar vein, we isolated Bacillus
strains from bovine chyme and screened the isolates for pro-
biotic potential, primarily utilizing antimicrobial activity as a
measure of efficiency. Isolation of novel strains with high
antimicrobial activity against pathogenic bacteria such as S.
aureus, P. aeruginosa, S. enterica, and K. pneumoniae is
highly desirable, as prevention of intestinal colonization by
pathogenic bacteria is one of the principal ways by which
probiotics bolster human and animal health. Other character-
istics, such as the ability to survive the passage through the
digestive tract and to successfully adhere to the intestinal
mucosa, should also be considered in order to evaluate the
capacity of a novel isolate as a potential probiotic.
Table 4 Minimum inhibitory
concentrations (MIC) of select
antibiotics against isolates
A, K, CH, E, V, N, CIP, S, and G





Isolate Minimum Inhibitory Concentration (MIC) μg/ml
A K CH E V N CIP S G
STF4 <1 <1 <1 <1 <1 4 <1 64 <1
STF8 16 64 8 2 4 64 <1 >128 16
STF9 64 64 64 8 4 64 <1 128 8
STF10 128 <1 8 4 8 64 <1 128 16
STF15 16 64 64 16 4 64 8 >128 8
STF25 128 64 64 128 128 128 16 128 16
STF26 32 16 32 32 32 32 4 32 16
Fig. 1 Agarose gel electrophoresis image of plasmid profile of isolates.
a, b, c, d, e, f and g represent STF4 (Paenibacillus xylanexedens), STF8
(Bacillus subtilis), STF9 (Bacillus subtilis), STF10 (Bacillus licheniformis),
STF15 (Bacillus pumilus), STF25 (Bacillus licheniformis), and STF26
(Bacillus pumilus), respectively
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Spores of certain prospective Bacillus probiotics were
found to be sensitive to the gastrointestinal tract (GIT) con-
ditions (Duc et al. 2004). However, the ability of probiotic
strains to survive in the GIT of the animal on which they are
used as feed supplement is of great importance, as the pro-
biotic bacteria cannot demonstrate their probiotic activities if
they cannot colonize the gastrointestinal tract. Therefore, re-
sistance of isolates to GIT conditions was tested with incuba-
tion in simulated gastric and intestinal fluids. Our results
revealed that spores of the isolates were resistant to gastric
fluid conditions after a 30-min incubation period, exhibiting
100 % survival rates. However, survival rates of STF15 and
STF25 spores displayed a marked decrease after 1 h incuba-
tion in simulated gastric fluids, while no reduction in viability
was observed in the other 5 isolates. Similarly, spores of all
isolates were found to be tolerant to simulated intestinal fluid
conditions, with 100 % survival rates after a 1-h incubation
period. However, survival rates decreased in spores of some
isolates for longer incubation periods. Vegetative cells, on the
other hand, were not as resistant as spores to stress conditions.
This result is expected, as spores of the genus Bacillus have
protective layers around the nucleoid in the spore core, mak-
ing spores extremely resistant to adverse environmental con-
ditions (Barbosa et al. 2005). Moreover, it has been reported
that, once ingested, spores ofBacillus isolates could germinate
in the GIT and display activity as vegetative cells in the host
animal (Chaiyawan et al. 2010; Casula and Cutting 2002).
Our results demonstrate that STF9, STF10, STF15, and
STF26 are capable of forming biofilm layers. Biofilm pro-
duction is desired for prospective probiotics, since it allows
the probiotic to remain longer in the GIT (Hong et al. 2008).
Biofilm formation provides protection for probiotic bacteria
against the harsh conditions of the GIT, supports spore
formation, and prevents pathogenic bacteria from holding
on to the GIT surface (Barbosa et al. 2005).
Antibiotic susceptibility is considered as one of the most
important characteristics for probiotic bacteria, since the resis-
tance genes could be transferred to pathogenic bacteria in the
intestinal tract and thus contribute to the creation of multidrug-
resistant pathogens (Patel et al. 2009; Schwarz et al. 2001;
Hong et al. 2005; Barbosa et al. 2005). This transfer mostly
occurs by plasmid-borne resistance genes (Schwarz et al.
2001). In this study, seven isolates chosen after the initial
screening were tested for antibiotic resistance against nine
widely utilized antibiotics. Of those isolates, only STF4 had
lower minimal inhibitory concentrations (MICs) than the break-
points used by SCAN (von Wright 2005) and could be consid-
ered susceptible to the antibiotics tested. Other isolates (STF8,
STF9, STF10, STF15, STF25, and STF26) were found to be
resistant to at least one antibiotic tested. After the observation
that most of the isolates displayed resistance to antibiotics,
plasmid isolation and visualization was performed to determine
whether this resistance is due to plasmid-borne resistance
genes. If such genes are not integrated in genomic DNA and
are instead carried on plasmids, theymay be transferred to other
bacteria in the environment and confer on them resistance to the
same antibiotic. This constitutes a potential health hazard if the
recipient bacteria are pathogenic, and the absence of plasmid
DNA should therefore be confirmed for an antibiotic-resistant
strain to be recommended as a prospective probiotic. As such,
plasmid isolation was performed for all seven bacteria and the
presence of plasmid was tested by performing gel electropho-
resis. Our results suggest that all the samples tested, with the
possible exception of STF25, carry potential antibiotic resis-
tance genes in their genomic DNA and bear no risk of transfer-
ring them to other pathogenic or non-pathogenic bacteria that
may be present in the environment (Hong et al. 2008). While it
is possible that large, low-copy number plasmids have not been
recovered by our isolation protocol, we find this possibility
unlikely as cultures were grown to confluence several times
in media lacking in antibiotics and, without the environmental
stresses selecting for their presence, plasmids encoding antibi-
otic resistance genes would likely have been lost.
The ability to adhere to and colonize in the GIT is an
important requirement for potential probiotics, as the capacity
to adhere increases the mean time of bacteria in the GIT and
Table 5 Adhesion, invasion
rates and cytotoxicity of Bacillus
isolates against HT-29
All results are given as the
percentage of the survivors
− sign indicates that no growth
on BHI was observed
Isolate Bacterial species Adhesion (%) Invasion (%) Cytotoxicity (%)
Normal Heat treated
STF4 Paenibacillus xylanexedens 2.500 0 2.9 0
STF8 Bacillus subtilis 0.010 0 95.2 68.6
STF9 Bacillus subtilis − − − −
STF10 Bacillus licheniformis 0.010 0 0 3.8
STF15 Bacillus pumilus 0.002 0 11.6 7.5
STF25 Bacillus licheniformis 0.100 0 7.8 0
STF26 Bacillus pumilus 0.008 0 8.5 0
ATCC 6633 Bacillus subtilis 0.466 0.050 4.5 2.7
RSHM709 Bacillus cereus 0.126 0.338 81.8 14.5
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allows greater periods of probiotic activity after oral introduc-
tion of the probiotic strain (Jacobsen et al. 1999; Saarela et al.
2000). Therefore, probiotic strains displaying stronger adhesion
to the GIT are considered to better modify the normal intestinal
microbiota, prevent the growth of pathogenic bacteria by com-
petitive exclusion, and induce immune system compared to the
non-adherent ones (Saarela et al. 2000; Patel et al. 2009). The
HT-29 cell line is used as a model for the testing of adhesion of
probiotic bacteria, as these cells differentiate into enterocytes
(Saarela et al. 2000; Patel et al. 2009). Thus, we used the HT-29
colon carcinoma cell line for the assessment of cell adhesion by
the prospective probiotic strains. In vitro adhesion assays sug-
gest that all isolates except STF9 were able to partially adhere
on the colon carcinoma cells, while STF4 had significantly
higher adherence ability than the others. The adhesion rates
observed were generally similar to the results obtained in other
studies related to Bacillus adhesion and our own results on
reference strains of B. subtilis and B. cereus (Hong et al. 2008;
Rowan et al. 2001). Though our isolates had relatively low
adhesion rates compared to previous records, STF4 again dis-
played higher adhesion than many strains in the literature.
Recent research suggests that members of Bacillus species
might induce important systemic diseases such as septicemia,
peritonitis, endocarditis, liver failure, and meningitis (Rowan
et al. 2001). Therefore, invasion studies were conducted for
our candidate probiotics. The test results suggest that none of
the isolates invaded the HT-29 cells, displaying similar results
to our B. subtilis reference strain. B. cereus RSHM709, how-
ever, was highly invasive. This result shows that our isolates
are non-invasive and incapable of causing invasion-related
diseases, though live animal tests should be conducted for
further confirmation.
MTT assay was used for detection of toxic materials in
bacterial supernatants. This assay was chosen as it has been
determined to be more reliable and sensitive than other cell
viability assays (European Commission 2000). In contrast to
previous methods, which were based on visual evaluation of
toxin-induced cell damage, MTT has the advantage of remov-
ing the subjective visual assessment from the assay. MTT is a
yellow, water-soluble tetrazolium salt, which is cleaved in the
mitochondria of metabolically active cells. In the presence of
living cells, MTT solution displays a color change as the
insoluble purple formazan is formed due to intramitochondrial
metabolization ofMTT (Rowan et al. 2001; Finlay et al. 1999;
Beattie and Williams 1999; European Commission 2000).
MTTassay is therefore highly sensitive for cellular respiration
and suitable for assessing cell viability and cytotoxicity, since
only living cells produce formazan reaction products (Beattie
and Williams 1999; Finlay et al. 1999; Rowan et al. 2001). In
this study, the cytotoxicity of cell-free supernatants was
assessed by using MTT salts. STF8 had high levels of heat-
stable cytotoxic materials in its cell-free supernatant, while
other isolates did not produce a significant level of toxic
materials. STF10 in particular displayed 0 % cytotoxicity.
For STF4, STF25, and STF26, heat treatment of the culture
supernatants eliminated toxicity to HT-29, suggesting that
toxic materials produced by those isolates are protein-based.
The relatively low toxicities of our isolates (bar STF8) is
expected as our isolates generally belong to the B. subtilis
group, which are generally considered safe for human and
animal use. Our B. subtilis reference strain likewise displayed
low cytotoxicity, while the B. cereus strain was highly toxic
prior to heating and possessed a heat-stable toxin that allowed
it to retain some toxicity after heat treatment.
In conclusion, Bacillus species were isolated from the GIT
of bovine and assessed with regards to their potential capacity
as probiotics. Among the isolates, STF4, STF10, STF15, and
STF26 appeared to have the highest potential as probiotic
candidates compared to other isolates, taking into account
their antimicrobial effects, resistance to simulated gastrointes-
tinal conditions, antibiotic susceptibility, colonization capaci-
ty, and lack of toxicity.
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